SURMODICS INC — Director's Dealing 2021

Mar 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-02-26

Reporting Person: KNIGHT SUSAN E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-26	Common Stock	M	5576	$21.31	Acquired	34290	Direct
2021-02-26	Common Stock	S	5576	$52.3593	Disposed	28714	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-26	Stock Option (right to buy)	$21.31	M	5576	Disposed	2021-12-03	Common Stock (5576)	Direct

Footnotes

F1: Reflects the weighted average price of 5,576 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on February 26, 2021 with sale prices ranging from $51.93 to $52.69 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The amount beneficially owned includes 11,721 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.

F3: Fully vested.